Federal_Agency_for_Medicines_and_Health_Products
The Federal Agency for Medicines and Health Products (FAMHP) of Belgium is responsible for the approval and registration of new medication in Belgium and for pharmacovigilance. Xavier De Cuyper is General Administrator of the agency.
This article needs additional citations for verification. (August 2022) |
The Dutch name is Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten (FAGG) and in French it is called Agence Fédérale des Médicaments et des Produits de Santé (AFMPS).
The agency succeeded the Directoraat-generaal Geneesmiddelen / Direction Générale des Médicaments of the Federal Public Service Health as the new Competent Authority on 1 January 2007.